“Early and Maintained Response Levels in Psoriasis Patients Treated With Tildrakizumab”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s41. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/990.